Study to determine black cohoshs safety for breast cancer patients
October 8th, 2008 - 1:21 pm ICT by ANI ( Leave a comment )Washington, Oct 8 (ANI): A researcher from the University of Missouri will conduct a study to determine how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer.
The risk of developing breast cancer increases as women age and reach menopause. Many women who have, or are at risk, for breast cancer take tamoxifen.
The drug prevents approximately half of breast cancers in women who are likely to develop the disease. However, when women take tamoxifen, they cannot take hormone replacement therapies to relieve menopausal symptoms.
Their options are limited to taking antidepressants that can have complications, enduring uncomfortable menopausal symptoms, or trying the black cohosh.
Hopefully, this study will provide evidence that black cohosh is safe to use for breast cancer patients. Currently, there is little reliable information guiding women in how they can use foods and botanical supplements to enhance their treatment or improve their quality of life, said Rachel Ruhlen, a postdoctoral researcher in the MU School of Medicine.
In order to study how black cohosh and tamoxifen interact, Ruhlen will use a group of rats prone to breast cancer, known as ACI rats.
Previous studies have found that human breast cancer is associated with life-time exposure of estrogen.
ACI rats, like humans, develop mammary tumours after exposure to estrogen. In a previous study, Ruhlen found that when ACI rats were treated with the human breast cancer drug tamoxifen, mammary tumour mass was reduced by 89 percent.
Many animal models of breast cancer differ in important ways from humans with breast cancer, Ruhlen said.
These models are useful in studying how human tumours grow and spread to other parts of the body, but fall short because of the difference in how human tumours begin.
However, mammary tumours in ACI rats share several key features with the majority of human breast cancers, particularly in how tumours start. Because the ACI rats develop tumours and can be treated in a way similar to humans, it is a relevant model for human breast cancer, Ruhlen added. (ANI)
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Folic acid supplements contribute to breast cancer risk: Study - Feb 12, 2011
- Taking tamoxifen to prevent breast cancer can save lives and cut medical costs - Mar 14, 2011
- Possible clues to tamoxifen resistance in breast cancer patients found - Mar 31, 2011
- Hot flushes tied to lower risk of breast cancer - Jan 26, 2011
- Estrogen helps women pile on pounds - Oct 06, 2011
- Protein from pregnancy hormone may avert breast cancer - Nov 25, 2009
- New way to halt expansion of breast cancer stem cells discovered - Nov 24, 2010
- Key enzyme that controls growth of breast cancer cells identified - Nov 19, 2010
- Anti-estrogen medication 'cuts risk of dying from lung cancer' - Jan 24, 2011
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Gene mutation ups blood-clot risk in women taking breast cancer treatment - Jun 17, 2010
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Soy-based compound in dietary supplement could cut menopausal hot flushes - May 01, 2010
- Preventive use of breast cancer drugs urged - Mar 28, 2011
Tags: animal models, black cohosh, botanical supplements, breast cancer, breast cancer drug, breast cancer increases, breast cancer patients, breast cancers, drug tamoxifen, hormone replacement therapies, human breast cancer, human tumours, mammary tumours, menopausal women, mu school, postdoctoral researcher, risk for breast cancer, tamoxifen, time exposure, women age